Healthcare Industry News: proton therapy
News Release - February 27, 2015
Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in AfricaVarian presenting cancer treatment strategy to governments and healthcare leaders at Africa Healthcare Summit in London
LONDON, Feb. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR), world leader in radiation therapy, is today reporting progress towards its goal of making advanced treatments systems more available for cancer patients across Africa. The company is presenting to government and healthcare leaders at the 2nd Africa Healthcare Summit.
"We are pleased at the opportunity to engage with governments and other stakeholders at the Africa Healthcare Summit, to further explore ways of extending access to advanced cancer care," says Burt Lang, Varian's managing director in Africa. "Cancer is growing rapidly in Africa and has become one of the continent's top healthcare concerns. Radiotherapy plays a vital and cost effective role in treating cancer and we are committed to making it available to more patients across the continent."
According to a study published in Lancet Oncology, only 23 out of 52 African countries have radiotherapy available for patients. The World Health Organization reports that by 2030 there will be some 1.6 million new cancer cases in Africa each year, resulting in 1.2 million deaths. The most common cancers in Africa are cancers of the cervix, breast, lung, liver and prostate.
Varian has installed more than 100 radiotherapy treatment systems in Africa over the last 25 years. The company recently announced major projects in Algeria, Egypt and South Africa. Varian has also installed equipment in several sub-Saharan nations including Ghana, Angola, Kenya, and Madagascar.
Varian manufactures and supplies products including linear accelerators and accessories, treatment simulators and treatment verification products, as well as software systems for planning cancer treatments and managing information and images for radiation oncology. It also supplies systems for proton therapy as well imaging components used in the diagnosis and treatment of cancer.
Access to Care in Africa
As part of its presentation to delegates at the summit, Varian is also reporting progress in its 'Access to Care' educational program in Africa. This collaborative initiative seeks to bridge the gap between skills levels and knowledge in well-equipped developed countries and those in developing nations, where modern equipment is being installed but the rollout is sometimes hampered by the lack of trained staff to operate the equipment. Under Varian's 'Access to Care' program, education hubs are being located strategically throughout the continent.
Neil Madle, Varian Medical Systems, +44 7786 526068
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing. Varian Medical Systems employs approximately 6,800 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
Source: Varian Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsLong-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
RaySearch Enters Into Interoperability Agreement With Varian
Varian Launches New Noona(R) Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare